497 related articles for article (PubMed ID: 9728449)
1. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. II. Reactions.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):159-69. PubMed ID: 9728448
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
[TBL] [Abstract][Full Text] [Related]
4. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
5. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
[TBL] [Abstract][Full Text] [Related]
6. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
7. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
[TBL] [Abstract][Full Text] [Related]
8. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
Dasananjali K; Schreuder PA; Pirayavaraporn C
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
[TBL] [Abstract][Full Text] [Related]
9. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
10. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
Khambati FA; Shetty VP; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
[TBL] [Abstract][Full Text] [Related]
11. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
12. The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia.
Van Veen NH; Meima A; Richardus JH
Lepr Rev; 2006 Dec; 77(4):356-65. PubMed ID: 17343222
[TBL] [Abstract][Full Text] [Related]
13. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients.
Reed NK; van Brakel WH; Reed DS
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):328-36. PubMed ID: 9401485
[TBL] [Abstract][Full Text] [Related]
14. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
[TBL] [Abstract][Full Text] [Related]
15. A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up.
Croft RP; Nicholls PG; Steyerberg EW; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Mar; 74(1):35-41. PubMed ID: 12669931
[TBL] [Abstract][Full Text] [Related]
16. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
[TBL] [Abstract][Full Text] [Related]
17. Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study).
Croft RP; Nicholls PG; Richardus JH; Smith WC
Lepr Rev; 2000 Mar; 71(1):18-33. PubMed ID: 10820984
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients.
Khambati FA; Shetty VP; Ghate SD; Capadia GD
Lepr Rev; 2009 Mar; 80(1):34-50. PubMed ID: 19472851
[TBL] [Abstract][Full Text] [Related]
19. Voluntary muscle testing and dynamometry in diagnosis of motor impairment in leprosy: a comparative study within the INFIR Cohort Study.
Suresh M; Nicholls PG; Das L; Van Brakel WH
Lepr Rev; 2008 Sep; 79(3):277-94. PubMed ID: 19009977
[TBL] [Abstract][Full Text] [Related]
20. Unexplained delayed nerve impairment in leprosy after treatment.
Rosenberg NR; Faber WR; Vermeulen M
Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
